BNET Industries
Market Cap:$117.1M
Last Fiscal Year Sales:$242.4M
- Public
- US
Dow Jones Description
Life Sciences Research is one of the world's leading Contract Research Organizations (CROs), providing pre-clinical and non-clinical biological safety evaluation research services to most of the world's leading pharmaceutical, biotechnology, agrochemical and industrial chemical companies. LSR's services are designed to meet the regulatory requirements of governments around the world, and are an indispensable part of safely developing new drugs to manage and improve mankind's health.
Chairman and Chief Executive Officer
Andrew BakerNumber of Employees 1,648
Peer Companies
NAICS Code : 541710
Recent Events
-
LSR Announces Third Quarter Results
-
BWS Financial Downgrades Life Sciences Research LSR to Hold; Suggests Considering CEO Offer
-
LSR Announces Second Quarter Results
-
Law Office of Brodsky & Smith, LLC Announces Class Action Lawsuit Against Life Sciences Research,...
-
Levi & Korsinsky, LLP Announces Class Action Lawsuit Against Life Sciences Research, Inc. - LSR
News & Analysis
Filter by
life sciences research inc. - All News and Analysis
Life Sciences Research to Be Acquired in Going Private Transaction
ValueHuntr submits: Life Sciences Research, Inc. LSR announced Thursday that it has entered into a definitive merger agreement to be acquired by Lion Holdings, Inc., an entity controlled by LSR’s Chairman and Chief Executive Officer, Andrew Baker, for $8.50 per share in cash. Mr. Baker currently beneficially owns approximately 17.5%...
Focusing on Medical Equipment
Trader Mark submits: I continue to watch my limit order for Thoratec THOR down in the $23s continue to mock me on a daily basis, so I'm going to "capitulate" and get at least a starter position going in this name here in the mid $27s. I wrote a detailed...
Life Sciences Research, Inc. -"LSR"-: Recommended Offer for Huntingdon Life Sciences Group plc -"Huntingdon"- - LSR Registration Statement Declared Effective
Business Editors PRINCETON, N.J.--BUSINESS WIRE--Dec. 21, 2001 On 16 October 2001, a recommended offer (the "Offer") was made by Life Sciences Research, Inc. ("LSR") for the entire issued share capital of Huntingdon Life Sciences Group plc ("Huntingdon"), as set out in the Offer Document of that date. ...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Brian Cass | President and Managing Director |
| Richard Michaelson | Chief Financial Officer |
| Julian T. Griffiths | Vice President of Operations |
| Phil Miller | Vice President |
| Frank W. Bonner | Director, Technology |
| Mark Bibi | General Counsel & Secretary |
| Gabor Balthazar | Director |
| Yaya Sesay | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Andrew Baker | Chairman and Chief Executive Officer |
| Afonso Junqueiras | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Life Sciences Research, Inc. | Chairman and Chief Executive Officer | Current |
| Corning Incorporated | Former | |
| Huntingdon | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| Life Sciences Research, Inc. | President and Managing Director | Current |
| Life Sciences Research, Inc. | Board of Directors | Current |
| Covance, Inc. | Vice President | Former |
| Huntingdon | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| Life Sciences Research, Inc. | Chief Financial Officer | Current |
| Life Sciences Research, Inc. | Secretary | Current |
| Huntsman Corporation | Director | Current |
| Corporate Analytics, Inc | Committee Member | Current |
| Unilab Corporation | Chief Financial Officer | Former |
| Unilab Corporation | Senior Vice President | Former |
| Huntingdon | Director of Strategic Finance | Former |
| Unilab Corporation | Treasurer | Former |
The services of Mr. Griffiths are provided through a service agreement between him and Huntingdon Life Sciences Limited (a wholly owned subsidiary of the Company). The service agreement appointed Mr. Griffiths as Finance Director of Huntingdon and he now holds the position of Vice President of Operations. Mr. Griffiths' service agreement will continue until terminated by Mr. Griffiths on six months' written notice or by Huntingdon Life Sciences Limited on 12 months' written notice. In the event of termination without "cause" following a "change in control", as defined, Mr. Griffiths would receive a payment equal to 2.99 times is annual salary plus an amount equal to 2.99 times all incentive compensation earned or received by Mr. Griffiths during the 12 months prior to termination. Mr. Griffiths received during 2006 an annual salary of (pound)165,000 gross and is entitled to permanent health insurance, life insurance, personal accident insurance, medical expenses insurance and pension benefits. Mr. Griffiths receives contributions to his private pension arrangements, equivalent to 20 percent of his basic annual salary. Mr. Griffiths' service agreement also provides for the payment of a bonus to Mr. Griffiths in the absolute discretion of the Company's Board.
| Organization | Position | Status |
|---|---|---|
| Life Sciences Research, Inc. | Vice President of Operations | Current |
| Covance, Inc. | Vice President of Analytical Services | Former |
| Life Sciences Research, Inc. | Director, Finance, Huntington Life Sciences Group | Former |
| Life Sciences Research, Inc. | Director | Former |
| Huntingdon | Board of Directors | Former |
Mr. Miller originally joined Ventana in 1988 as acting CEO and Vice President of Research and Development. Prior to his joining Ventana, Mr. Miller held management positions with Abbott Laboratory's Research and Development division. From 1994 to 2002, Mr. Miller held senior management positions in R&D at Nichols Institute Diagnostics, a Division of Quest Diagnostics. Mr. Miller returned to Ventana in September 2002 and is currently Vice President of Life Sciences Research and Development. Mr. Miller holds a BS in Chemistry from the University of Indiana.
| Organization | Position | Status |
|---|---|---|
| Ventana Medical Systems, Inc. | Senior Vice President, Discovery | Current |
| Life Sciences Research, Inc. | Vice President | Current |
| Nichols Institute Diagnostics | Former | |
| Quest Diagnostics Incorporated | Former | |
| University of Indiana | Bs In Chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Life Sciences Research, Inc. | Director, Technology | Current |
| Life Sciences Research, Inc. | Director, Technology | Former |
| Organization | Position | Status |
|---|---|---|
| Life Sciences Research, Inc. | General Counsel & Secretary | Current |
| Life Sciences Research, Inc. | Board of Directors | Current |
| Unilab Corporation | Executive Vice President | Former |
| Unilab Corporation | General Counsel | Former |
| Unilab Corporation | Secretary | Former |
| Organization | Position | Status |
|---|---|---|
| Life Sciences Research, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Life Sciences Research, Inc. | Director | Current |
| Huntingdon | Board of Directors | Former |
| Unilab Corporation | Board Member | Former |
| Columbia Business School | Former | |
| Columbia University Law School | Former |
| Organization | Position | Status |
|---|---|---|
| Life Sciences Research, Inc. | Director | Current |
Executive News
-
Small Deals, Big Issues
-
Law Office of Brodsky & Smith, LLC Announces Class Action Lawsuit Against Life Sciences Research, Inc.
-
Levi & Korsinsky, LLP Announces Class Action Lawsuit Against Life Sciences Research, Inc. - LSR
-
Levi & Korsinsky, LLP Announces Class Action Lawsuit Against Life Sciences Research, Inc. - LSR
-
Levi & Korsinsky, LLP Announces Class Action Lawsuit Against Life Sciences Research, Inc. - LSR
-
Life Sciences Research to Be Acquired in Going Private Transaction
-
Midas and HSN Lead Drop in Consumer Shares
-
Life Sciences Research, Inc. to be Acquired in Going Private Transaction for $8.50 Per Share in Cash
-
Life Sciences Research To Be Acquired By Lion Holdings For $8.50 Per Share In Cash - Quick Facts
-
Life Sciences Research, Inc. to be Acquired in Going Private Transaction for $8.50 Per Share in Cash
-
Life Sciences Research, Inc. to be Acquired in Going Private Transaction for $8.50 Per Share in Cash



